Allspring Global Investments Holdings LLC lessened its holdings in shares of Qiagen N.V. (NYSE: QGEN

More than 1,600 U.S. cases of cyclosporiasis have been confirmed since May 2026 as infections linked

GERMANTOWN, Md., & VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; F

VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today

Private equity giants circle Qiagen (QGEN) with potential bids of $50/share. Get the details on the

Morgan Stanley analyst Steve Beuchaw upgrades Qiagen (NYSE:QGEN) from Equal-Weight to Overweight

Planned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcui

QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA))) announced at the 2026 BIO-IT World Conference &a

Stifel analyst Daniel Arias maintains Qiagen (NYSE:QGEN) with a Hold and lowers the price target

Co-founder and former CEO Dr. Metin Colpan to become Honorary Chairman of the Supervisory Board afte

TD Cowen analyst Dan Brennan maintains Qiagen (NYSE:QGEN) with a Hold and lowers the price target

Ambition to support high-throughput laboratories in efficiently scaling latent tuberculosis (TB) scr

Qiagen (NYSE:QGEN) FY2026 expected to be more than $2.43 vs $2.51 Est. affirms FY2026 sales outlook

JP Morgan analyst Casey Woodring maintains Qiagen (NYSE:QGEN) with a Overweight and lowers the pr

Citigroup analyst Patrick Donnelly maintains Qiagen (NYSE:QGEN) with a Neutral and lowers the pri

Barclays analyst Luke Sergott maintains Qiagen (NYSE:QGEN) with a Equal-Weight and lowers the pri

Analysts upgraded Qiagen, Armstrong World, T-Mobile, Crane Co, and Centene Corp stocks, with price t

Analysts change outlook & ratings for QGEN, AWI, CR, ATEN, PLUG, SBUX, CECO, CNC. Price targets

Baird analyst Catherine Schulte upgrades Qiagen (NYSE:QGEN) from Neutral to Outperform and lowers

Tech stocks slide as OpenAI's user growth miss reignites AI capex skepticism, while oil rallies

Barclays analyst Luke Sergott downgrades Qiagen (NYSE:QGEN) from Overweight to Equal-Weight and a

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced newly published clinical and

Deutsche Bank analyst Jan Koch upgrades Qiagen (NYSE:QGEN) from Hold to Buy and maintains the pri

QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA))) today announced that the U.S. Food and Drug

JP Morgan analyst Casey Woodring maintains Qiagen (NYSE:QGEN) with a Overweight and raises the pr

Stifel analyst Daniel Arias maintains Qiagen (NYSE:QGEN) with a Hold and raises the price target

Qiagen (NYSE:QGEN) FY2026 expected to be more than $2.50 vs $2.66 Est. FY2026 Revenue expected to

Qiagen (NYSE:QGEN) Q1 expected to be more than $0.54 vs $0.60 Est. Q1 Revenue expected to be more

Qiagen (NYSE:QGEN) reported quarterly earnings of $0.62 per share which missed the analyst consensus

Deutsche Bank analyst Jan Koch downgrades Qiagen (NYSE:QGEN) from Buy to Hold and raises the pric

Qiagen is reviewing strategic options, including a potential sale, after renewed takeover interest f

Wall Street tumbled on Tuesday, reopening after the Martin Luther King Jr. Day holiday, as risk-off

https://www.bloomberg.com/news/articles/2026-01-20/qiagen-is-said-to-consider-strategic-options-amid

The last day of trading of the pre-split shares on the New York Stock Exchange and the Frankfurt Sto

Return of approximately $500 million – maximum approved by shareholders – set to be completed on Jan

Barclays analyst Luke Sergott maintains Qiagen (NYSE:QGEN) with a Overweight and raises the price

Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for it

  During the session on Thursday, 461 stocks hit new 52-week lows.

  Monday saw 825 companies set new 52-week lows.